Brinter

Brinter

Private
Winston-Salem, North CarolinaHealthcare & Life Scienceshttps://brinter.com

Last Round

Grant

Dec 11, 2024

Total Funding Raised

$1.58M

Momentum Score

25 /100

Company Overview

Brinter is an American-Finnish biotechnology company that develops 3D bioprinting solutions for the life sciences industry. The company provides bioprinters, materials, and services to pharmaceutical companies, universities, and research centers to advance applications in regenerative medicine and tissue engineering. Brinter is also developing its own 3D bioprinted medical implants, with a focus on orthopedics, that are designed to be bioresorbable and support the body's natural healing process. The company was established as a spin-off from 3DTech Ltd and aims to make bioprinting technology more accessible for research and clinical use.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, 3D Printing, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprintingbioprintersregenerative medicinetissue engineeringbioprinted implantsbio-inkstissue modelspatient-specific implantsbiomanufacturingmulti-material printingdrug discovery toolsbiotech equipmentbioresorbable implantsmultifluidic printingphotonic disinfection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brinter Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Brinter Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2024
AcceleratorOct 28, 2024
AcceleratorMar 11, 2024
SeedJun 10, 2021

Key People

Founding team and executive leadership

Matthew Dean Brovold

Chief Science Officer And Co-Founder

Founding Team

Tom A.

CEO, Co-Founder And Board Director

Founding Team

Theo Arhio

Chief Operating Officer

Executive Team

Brinter Investors

Notable investors and investment history

InvestorRounds
InnovestorSeed
TechstarsAccelerator
AthensmedSeed

Brinter Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brinter Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brinter's valuation, stock price, and market status.

Firmographic Details

HeadquartersWinston-Salem, North Carolina
Employee Range11
Year Founded2020
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.